Cite

HARVARD Citation

    Carlson, C. et al. (2016). Amyloid‐related imaging abnormalities from trials of solanezumab for Alzheimer's disease. Alzheimer's & dementia. 2 (1), pp. 75-85. [Online]. 
  
Back to record